Supplementation of Dual Probiotic Strains Reduced Fasting Triglyceride and Enhanced Apolipoprotein A-V Levels

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 128 participants.

Also called NCT02215694

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose basic science
Phase
Phase 3
Enrolled
  • 128 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02215694
Other papers using this trial's data
  • The triglyceride-lowering effect of supplementation with dual probiotic strains, Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032: Reduction of fasting plasma lysophosphatidylcholines in nondiabetic and hypertriglyceridemic subjects Nutrition, metabolism, and cardiovascular diseases : NMCD, 2015-08 DOI, PubMed 26044516

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02215694. Randomized; double masking; primary purpose basic science. Start 2012-06 (registry gives no type); primary completion 2014-03 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Supplementation of Dual Probiotic Strains Reduced Fasting Triglyceride and Enhanced Apolipoprotein A-V Levels
Condition
Hypertriglyceridemia
Intervention (Dietary supplement)
dual probiotics
Intervention (Dietary supplement)
placebo
Lead sponsor
Yonsei University (class: other)

Record details

Record id
cardio:ct-nct02215694
Content hash
3efdb37910d289f85046e1ddc22ab86a2cbbae7d3cf4d205e8b7f89a05551443